Tiban, Mylene .

HRN: 17-76-31  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2025
AMPICILLIN 1GM (VIAL)
06/24/2025
07/01/2025
IV
2g
Q6hrs
PROM
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: